Government Royalties on Sales of Pharmaceutical and Other Biomedical Products Developed with Substantial Public Funding - Illustrated with the Technology Transfer of the Drug-Eluting Coronary Stent (Paperback)

This study develops a detailed description of the successful technology transfer of an invention - the drug-eluting coronary stent - originating in intramural research within the US National Institutes of Health. The history of the commercialization of the invention is used to illustrate a new policy, proposed and explained in this study, for the payment to the government of royalties on the sales of biomedical products developed with substantial public funding provided through indirect as well as direct funding avenues. The proposed policy addresses concerns about the high prices that taxpayers as consumers pay for biomedical products that were developed with funding from the taxpayers as investors. The study explains the theoretical circumstances in which the policy would not adversely affect the appropriate level of R&D investment, and then uses the history of the drug-eluting coronary stent as an example where biomedical R&D is consistent with those circumstances.

General

Imprint:	Now Publishers Inc
Country of origin:	United States
Series:	Annals of Science and Technology Policy
Release date:	September 2021
First published:	2021
Authors:	Robert S. Danziger • John T. Scott
Dimensions:	234 x 156mm (L x W)
Format:	Paperback
Pages:	112
ISBN-13:	978-1-68083-820-6
Categories:	Books > Science & Mathematics > Science: general issues > Science funding & policy
LSN:	1-68083-820-2
Barcode:	9781680838206

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!